Find uplifting stories about heroes, innovations, and solutions
7257 results for "screwworm treatment"
Pet owners in affected areas now have access to an affordable, fast-acting treatment that kills screwworm larvae within hours. The FDA's emergency authorization provides a crucial new tool as health officials work to contain the pest following recent U.S. detections.
A newly approved topical solution gives U.S. cattle producers their first effective tool to prevent and treat New World screwworm infestations that threaten the agricultural industry. The pour-on treatment also controls cattle fever tick, offering ranchers multiple protections in one application.
The FDA has greenlit an emergency treatment to protect dogs and cats from New World screwworm, a dangerous parasite spreading in the southern U.S. This fast-tracked approval gives veterinarians a powerful new tool to save infected pets.
Pet owners can now buy a fast-acting treatment that kills screwworm larvae within hours, giving families a powerful new tool to protect their dogs and cats. The FDA's emergency approval comes as officials work to contain the parasite's spread while keeping most U.S. pets safe.
%3Amax_bytes(150000)%3Astrip_icc()%2F2208-05-074_cattle-0930040062ba48a497b4d462c206b168.jpg)
Ranchers and farmers now have better tools to protect their animals from a dangerous parasite that's been threatening U.S. livestock. The FDA just approved new sizes and expanded use of the only over-the-counter treatment available.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
A new HIV pill taken just once a week appears as effective as daily treatment in major studies. Over six million South Africans currently on daily HIV medication could benefit from simpler treatment.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
Scientists have enrolled the first patient in a groundbreaking trial to find effective treatments for the deadly Bundibugyo strain of Ebola in the Democratic Republic of Congo. The trial brings hope to a region where more than 1,400 people have been infected since May, with currently no approved treatments available.
BestCare Treatment Services broke ground on Oregon's only residential treatment center designed specifically for Latino men struggling with substance use disorder. The culturally tailored facility will provide care entirely in Spanish, addressing critical language and cultural barriers that often prevent people from seeking help.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Men with spreading prostate cancer can now postpone harsh hormone therapy for over two years thanks to a targeted radiation treatment that leaves healthy tissue untouched. A quarter of patients showed no tumors after treatment.
A new high dose version of an SMA treatment just won FDA approval, offering faster results for babies and children fighting this devastating muscle disease. The breakthrough gives families a more powerful option against a condition that once had no treatment at all.
Patients with muscle-invasive bladder cancer now have the first major treatment breakthrough in over 20 years. A new drug combination keeps 80% of patients disease-free two years after treatment, compared to 66% with standard chemotherapy.
Showing 20 of 7257